CD44 and breast cancer: FEZF1-AS1 knockdown decreased the CD44+/CD24- ratio, BCSC cells' capacity to form mammospheres, and the expression of stemness factors (Nanog, OCT4, SOX2), indicating that FEZF1-AS1 silencing has a suppressive effect on the stemness of breast cancer.